CONWAY ROBERT E

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 27% 8.2% 15.1%
Success rate 69% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
CONWAY ROBERT E's trades of Oruka Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
224.11
Quantity 84,939 -31.5%
Value US$283,751
Transaction date
Purchase
Price
236.81
Quantity 80,788 +6.2%
Value US$4,808,627
Transaction date
Purchase
Price
463.69
Quantity 45,739 +10.9%
Value US$3,322,130
Transaction date
Purchase
Price
4.28
Quantity 5,000 +33.3%
Value US$21,400
Transaction date
Purchase
Price
4.66
Quantity 3,056 +25.6%
Value US$14,241
Transaction date
Purchase
Price
4.77
Quantity 10,000 +514.4%
Value US$47,660
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-13 2021-05-12
B Purchase
84,939 -31.5%
224.11
US$283,751 		84,939 -31.5% 224.11 US$283,751
2021-05-06 2021-05-05
B Purchase
80,788 +6.2%
236.81
US$4,808,627 		80,788 +6.2% 236.81 US$4,808,627
2020-12-21 2020-12-18
B Purchase
45,739 +10.9%
463.69
US$3,322,130 		45,739 +10.9% 463.69 US$3,322,130
2020-11-23 2020-11-19
B Purchase
10,000 +66.7%
8.03
US$80,300 		10,000 +66.7% 8.03 US$80,300
2020-09-25 2020-09-25
B Purchase
5,000 +33.3%
4.28
US$21,400 		5,000 +33.3% 4.28 US$21,400
2020-09-24 2020-09-22
B Purchase
3,056 +25.6%
4.66
US$14,241 		3,056 +25.6% 4.66 US$14,241
2020-09-21 2020-09-21
B Purchase
10,000 +514.4%
4.77
US$47,660 		10,000 +514.4% 4.77 US$47,660